| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinological Oncology |
Servizio di Anatomia ed Istologia Patologica, Presidio Ospedaliero Vittorio Emanuele II; and Istituto di Medicina Interna e di Malattie Endocrine e Metaboliche, Cattedra di Endocrinologia (A.B., G.M.S., R.V.), and Cattedra di Chirurgia (O.I., R.V.), University of Catania, Catania, Italy 95123
Address all correspondence and requests for reprints to: Antonino Belfiore, M.D., Istituto di Medicina Interna e di Malattie Endocrine e del Metabolismo, Cattedra di Endocrinologia, P.zza S. Maria di Gesù 1, 95123 Catania, Italy. E-mail: endo.uni.ct{at}mail.tau.it
We evaluated the occurrence, tissue distribution, and prognostic value of tumor-associated macrophages in 121 papillary thyroid carcinomas using immunohistochemical staining with anti-CD68 antibody in archival paraffin-embedded sections. Lymphocytic infiltration and dendritic cell presence were also evaluated. Three groups were identified according to the presence and characteristics of macrophages: 1) tumors without evidence of infiltrating macrophages: (n = 35); 2) tumors with infiltrating macrophages but no evidence of neoplastic cells phagocytosis (n = 68); and 3) tumors with infiltrating macrophages and in situ evidence of active neoplastic cell phagocytosis (n = 18).
Neoplastic cell phagocytosis by macrophages was positively correlated with both lymphocytic infiltration and dendritic cells (P = 0.0000), whereas it was negatively correlated with vascular invasion (P = 0.0032). Distant metastases developed in none of the 18 tumors with neoplastic cell phagocytosis, but occurred in 15 of 103 of the remaining tumors (P = 0.0647) and were significantly and negatively associated with lymphocytic infiltration or dendritic cells.
The present study indicates, therefore, that immune reaction, involving neoplastic cell phagocytosis by macrophages and lymphocytic infiltration, plays a role in the development of distant metastases in patients with papillary thyroid cancer.
This article has been cited by other articles:
![]() |
C. Mesa Jr., M. Mirza, N. Mitsutake, M. Sartor, M. Medvedovic, C. Tomlinson, J. A Knauf, G. F. Weber, and J. A. Fagin Conditional Activation of RET/PTC3 and BRAFV600E in Thyroid Cells Is Associated with Gene Expression Profiles that Predict a Preferential Role of BRAF in Extracellular Matrix Remodeling. Cancer Res., July 1, 2006; 66(13): 6521 - 6529. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mineo, A. Costantino, F. Frasca, L. Sciacca, S. Russo, R. Vigneri, and A. Belfiore Activation of the Hepatocyte Growth Factor (HGF)-Met System in Papillary Thyroid Cancer: Biological Effects of HGF in Thyroid Cancer Cells Depend on Met Expression Levels Endocrinology, September 1, 2004; 145(9): 4355 - 4365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shimura, G. Yang, S. Ebara, T. M. Wheeler, A. Frolov, and T. C. Thompson Reduced Infiltration of Tumor-associated Macrophages in Human Prostate Cancer: Association with Cancer Progression Cancer Res., October 1, 2000; 60(20): 5857 - 5861. [Abstract] [Full Text] |
||||
![]() |
N. Mitsiades, V. Poulaki, G. Mastorakos, S. Tseleni-Balafouta, V. Kotoula, D. A. Koutras, and M. Tsokos Fas Ligand Expression in Thyroid Carcinomas: A Potential Mechanism of Immune Evasion J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2924 - 2932. [Abstract] [Full Text] |
||||
![]() |
G. Pellegriti, A. Belfiore, D. Giuffrida, L. Lupo, and R. Vigneri Outcome of Differentiated Thyroid Cancer in Graves' Patients J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2805 - 2809. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |